Gilead Sciences (GILD) priced a $3 billion public offering of senior unsecured notes, the company said late Thursday.
The offering comprises $500 million of 4.25% notes maturing in 2028, $1 billion of 4.4% notes maturing in 2029, $1 billion of 4.6% notes maturing in 2031, and $500 million of 4.9% notes maturing in 2034.
The company expects the offering to close Wednesday and plans to use the net proceeds for general corporate purposes.
Gilead shares were up 1% in premarket activity Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments